Mucin synthesis in immortalized canine tracheal epithelial cells

Area of Science:

• Cell Biology
• Biochemistry
• Respiratory Medicine

Background:

• Studying mucin synthesis regulation in canine tracheal epithelial cells requires a continuously synthesizing cell line.
• Existing methods may not provide a stable model for long-term mucin research.

Purpose of the Study:

• To establish an immortalized canine tracheal epithelial cell line (CT1) for continuous mucin synthesis.
• To characterize the mucin produced by the CT1 cell line and compare it to native canine tracheal mucin (CTM).

Main Methods:

• Immortalization of primary canine tracheal epithelial cells using human papillomavirus (type 18) E6 and E7 genes.
• Reverse transcriptase-polymerase chain reaction (RT-PCR) to detect canine tracheal mucin (CTM) mRNA.
• Metabolic labeling with glucosamine and analysis of synthesized mucin glycoprotein properties (buoyant density, chondroitinase treatment).

Main Results:

• The established CT1 cell line expressed CTM mRNA and synthesized high-molecular-weight mucin glycoprotein.
• The synthesized mucin exhibited properties similar to native CTM, including buoyant density.
• The mucin produced was confirmed not to be a proteoglycan.

Conclusions:

• The CT1 cell line is a viable model for studying mucin biosynthesis and regulation in canine tracheal epithelial cells.
• This immortalized cell line provides a continuous source of mucin glycoprotein for further research.
• CT1 cells express epithelial antigens, confirming their epithelial origin.